The subsequent mineralization of these precursors and removal of the former solid templates may lead to mesostructures with other compositions and crystalline frameworks [1, 13, 19].
Novel cancer therapies are based on the assumption that reconstitution or forced enhancement of respiration within solid tumors may lead to growth inhibition and cell death [10], [28], [29].
Detachment of large amount of Cu2+ ions having higher diffusion activity than solid particles may lead to increase in cytotoxicity.
Combining novel agents with established chemotherapeutic drugs in palliative treatment of solid cancers may lead to modest improvements in response rates, progression-free and overall survival.
The heterogeneity of tumour biology and drug delivery to solid tumours may lead to variability in the results, making the interpretation of tumour biopsy and imaging data extremely challenging.
Further investigations to illuminate the intimate mechanisms of hypoxia and reoxygenation inducing solid tumors metastasis may lead to new molecular therapies besides conventional treatments against malignant solid tumors.
The formation of solid intermediate compounds may lead to equipment clogging and plant shutdown in ammonia-based CO2 capture processes.
Biofilm reactors provide passive immobilization of cells onto the solid support, which may lead to higher productivity.
But in cases like the line test, where social influence can sometimes unhinge even our most solid convictions, it may lead us (and our institutions) astray.
